(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 5g

(R)-2-(2-Chloro-6-fluorophenyl)pyrrolidine hydrochloride, 95.0%, 250mg

5-Bromonaphtho[1,2-d][1,2,3]oxadiazole, 98%, 1g

4-Fluoro-2-methylpyridine, 95.0%, 500mg

Azathioprine>98.0%(HPLC)(T)5g

1-Methyl-1H-benzimidazole-5-carboxylic acid, 95.0%, 5g

[3-(methoxymethoxy)phenyl](pyridin-4-yl)methanone, 95.0%, 5g

3-Fluorobenzylamine, 95.0%, 25g

N,3-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 100mg

4-Bromo-3-nitroaniline>98.0%(GC)1g

1,2-Dichloro-4-methoxy-3-nitrobenzene, 97.0%, 5g

2,5-Dimethylpyridine, 95.0%, 100g

4-(1-Methyl-1h-pyrazol-4-yl)-1,3-thiazole-2-carbaldehyde, 95%, 5g